Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong – Clinical outcomes, barriers to vaccination, and urgency for reform()

INTRODUCTION: Hong Kong has had a low incidence of COVID-19 vaccine related anaphylaxis, partly due to its Vaccine Allergy Safety (VAS) guidelines for screening those at higher risk of COVID-19 vaccine-associated allergic reactions. We characterize the initial experience of the VAS clinics, as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Valerie, Mok, Sabrina Wing Shan, Chan, June King Chi, Leung, Wai Yan, Ho, Carmen Tze Kwan, Au, Elaine Y.L., Lau, Chak Sing, Lee, Tak Hong, Li, Philip Hei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685183/
https://www.ncbi.nlm.nih.gov/pubmed/34956434
http://dx.doi.org/10.1016/j.waojou.2021.100622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685183/
https://www.ncbi.nlm.nih.gov/pubmed/34956434
http://dx.doi.org/10.1016/j.waojou.2021.100622

Ejemplares similares